<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01307514</url>
  </required_header>
  <id_info>
    <org_study_id>0417-08-HMO</org_study_id>
    <nct_id>NCT01307514</nct_id>
  </id_info>
  <brief_title>Effects of Heating Massaging Vibrating Vicinity of the Insulin Delivery Site</brief_title>
  <official_title>Protocol for Evaluation of the Effects of Heating Massaging Vibrating or Application of Topical Agent on the Vicinity of the Insulin Delivery Site</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hadassah Medical Organization</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hadassah Medical Organization</source>
  <brief_summary>
    <textblock>
      The aim of this experiment is to test the pharmacodynamics and pharmacokinetics of insulin
      analogs and their dependence on external and physiological alterations. The investigators
      plan compare the pharmacodynamics of insulin analog delivery in regular conditions and in the
      presence of increased perfusion of the delivery site, achieved by way of local warming,
      movement and topical application of Capsaicin cream. The investigators will also test the
      effect of local heating and topical application of Capsaicin cream on the post prandial
      glucose levels following a bolus.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>November 2008</start_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Crossover</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Anticipated">100</enrollment>
  <condition>DIABETES</condition>
  <eligibility>
    <study_pop>
      <textblock>
        The participants will be patients with insulin dependent diabetes using standard insulin
        injections or continuous insulin infusion pumps.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Participant age between 18- 65 years old

          2. Type I or Type II diabetes

          3. HbA1c 6-12%

          4. Does not suffer from sever hypertension, kidney, liver or heart disease

          5. Does not suffer from active Ischemic heart disease

          6. Is willing to sign the consent form

        Exclusion Criteria:

          1. Participants age &lt; 18 or &gt; 65

          2. Pregnancy

          3. Breast feeding women

          4. Un-controlled diabetes, HbA1c values &gt; 12% range

          5. Suffers from active Ischemic heart disease

          6. Alcohol addiction

          7. Is not prepared to signed the informed consent
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Itamar Raz, MD</last_name>
    <phone>00-972-2-6778021</phone>
    <email>ntv502@netvision.co.il</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Arik Tzukert, DMD</last_name>
    <phone>00 972 2 6776095</phone>
    <email>arik@hadassah.org.il</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hadassah Medical Organization,</name>
      <address>
        <city>Jerusalem</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>September 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 2, 2008</study_first_submitted>
  <study_first_submitted_qc>March 1, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 3, 2011</study_first_posted>
  <last_update_submitted>March 1, 2011</last_update_submitted>
  <last_update_submitted_qc>March 1, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 3, 2011</last_update_posted>
  <responsible_party>
    <name_title>Prof. Raz</name_title>
    <organization>Hadassah Medical Organization</organization>
  </responsible_party>
  <keyword>DIABETES</keyword>
  <keyword>PHARMACOKINETICS</keyword>
  <keyword>PHARMACODYNAMICS</keyword>
  <keyword>INSULIN</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

